Sectoral Asset Management »

Definium Therape shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.7M 78k 47.04

More positions owned by Sectoral Asset Management

Contineum Therapeutics Cl A (CTNM)
Shoulder Innovations Common Stock (SI)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Oruka Therapeutics (ORKA)
Biontech Se Sp Adr (BNTX)
Definium Therapeutics Com Shs (DFTX)
Dex (DXCM)
Arcus Biosciences Incorporated (RCUS)
Amgen (AMGN)
Summit Therapeutics (SMMT)
Irhythm Technologies (IRTC)
Abbvie (ABBV)
Merck & Co (MRK)

View all positions for Sectoral Asset Management

Top funds holding Definium Therape

BlackRock
venBio Select Advisor
Driehaus Capital Management
Jupiter Topco
FMR
Geode Capital Management
Henderson Group
Capital Research and Management Company - Division 3
Octagon Capital Advisors
Wellington Management Company
Deep Track Capital
State Street Corporation
Citadel Advisors
Commodore Capital
Susquehanna International

View all funds holding Definium Therape